Stage III Adrenal Cortex Carcinoma Clinical Trials in Atlanta, Georgia

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer